RELATE: Expert Insights on When and How to Use RLT in Canadian Patients with mCRPC
RELATE: Expert Insights on When and How to Use RLT in Canadian Patients with mCRPC
Speakers: David Laidley & Ramy Saleh
Objectives
By the end of this program, participants can expect to:
- Identify patients with mCRPC who would benefit from treatment with RLT
- Counsel patients on the practicalities of RLT administration
- Assess treatment response and manage AEs associated with RLT
ACCREDITATION
This activity is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by CUA. You may claim a maximum of 1 hour of credit.
This program has received financial support from Novartis in the form of an educational grant.